Skip to content
My WebMD Sign In, Sign Up
Font Size

How Fecal Transplant Eases Tough Infection

Goal is an easier delivery method for treating C. difficile

WebMD News from HealthDay

By Alan Mozes

HealthDay Reporter

TUESDAY, June 17, 2014 (HealthDay News) -- Patients suffering from the nasty bacterial infection known as Clostridium difficile often must choose between standard antibiotics and a procedure known as fecal transplantation to deal with the digestive tract disorder.

The fecal transplant involves harvesting good bacteria from the stool of a healthy donor and inserting it into the intestines of a sick patient.

The process often succeeds where antibiotics fail -- by restoring healthy bacteria and functioning to the recipient's gut, new research suggests. But the procedure is poorly understood and invasive.

Researchers want to fashion a new treatment with all the upside and none of the downside for treating recurrent C. difficile, one of the most common infections acquired in American health care settings.

"Basically what we're trying to do is figure out why fecal transplantation works," said Dr. Vincent Young, an associate professor in the division of infectious diseases at the University of Michigan in Ann Arbor.

"We know we have to replace the patient's bacteria. But we don't know what role they play once we do," Young added.

"It could be that the bacteria we use needs to be living. Or it could be that the bacteria produce something that we can isolate, and then deliver directly to patients without living bacteria and, therefore, without fecal matter. That's the hope," he said.

Young and his team published their findings in the May/June online edition of mBio.

The U.S. Centers for Disease Control and Prevention estimates that about 14,000 Americans die of C. difficile each year. Most at risk are older people who take antibiotics and also get medical care, the CDC noted. It's believed antibiotics disrupt the balance of bacteria in the gut, increasing susceptibility to infection.

Antibiotics are one option for treating the severe diarrhea, vomiting and abdominal discomfort that can follow infection.

However, roughly 40 percent of treated patients experience disease recurrence. What's more, antibiotics sweep out good bacteria along with the bad.

As an alternative, fecal transplantation essentially places an army of good bacteria into besieged territory, where it "smart-bombs" only the bad C. difficile bacteria that might otherwise elude antibiotics.

How it does that remains unclear. But the process, which reportedly dates back to 4th-century China, has been available to American patients since the 1950s. By some estimates, the success rate exceeds 90 percent.

The problem: Fecal transplants are delivered either by colonoscopy, by a tube threaded through the stomach, or by enema -- all somewhat unpalatable therapies.

Although Canadian researchers last fall reported success with a pill form of fecal delivery, that method is not yet approved by the U.S. Food and Drug Administration for general use.

For Young's study, the researchers conducted a comparative DNA analysis of bacteria found in stool samples from 14 C. difficile patients at a clinic in Minnesota.

Today on WebMD

myth and facts about constipation
Slideshow
what is ibs
Article
 
toilet paper
Quiz
Fastfood
Article
 

top foods for probiotics
Slideshow
couple eating at cafe
Article
 
sick child
Slideshow
Woman blowing bubble gum
Slideshow
 

Woman with crohns in pain
Slideshow
Woman with stomach pain
Slideshow
 
diet for diverticulitis
Video
what causes diarrhea
Video